International Patent: PREPARATION AND USE OF POSITRON EMISSION TOMOGRAPHY PROBE TARGETING KRAS G12D MUTATION

GENEVA, Oct. 5 -- BEIJING GILUNTIDE PHARMACEUTICAL CO., LTD. filed a patent application (CN2026/086383) for “PREPARATION AND USE OF POSITRON EMISSION TOMOGRAPHY PROBE TARGETING KRAS G12D MUTATION”. With publication no. WO/2026/201097, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 519/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....